UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services



Document Type

Technical Report


Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacy Administration, Policy and Regulation


Pipeline Trends is produced by UMass Medical School’s Clinical Pharmacy Services division and is distributed at least once a year. This edition provides a comprehensive overview of:

  • Promising New Agents: Abaloparatide, Cannabidiol, Dupilumab, and others
  • Projected Generic Entry: Strattera®, Tamiflu®, Truvada®, Zetia®, and others
  • Investigational Indications: Cabozantinib and Tofacitinib
  • FDA Updates
  • Industry Trends

Rights and Permissions

© University of Massachusetts Medical School 2016


pharmacy, pharmaceuticals, drugs, therapeutic agents, drug therapy



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.